BeStock  

Labcorp Holdings LH

US equityMarket cap rank #664Diagnostics & ResearchInfectious DiseaseCRO
$367.13 −$1.75 (-0.47%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $367.13 0.00%
Open$371.48
Prev close$368.88
Day range$366.33 – $372.50
Volume890.6K
Market cap$29.81B
P/E (TTM)30.1
Dividend yield0.78%

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

LH at a glance

Labcorp Holdings (LH) is trading at $367.13, down 0.47% on the day. Its market value of $29.81B makes it the 664th largest of the 3753 companies we follow.

Over a full year the shares have ranged across $243.20 to $375.10, which puts the current price roughly 94% of the way up that band. Holders are ahead 39.6% over twelve months, and up 8.4% across the last three months.

On the chart it holds above both the 50-day ($334.76) and 200-day ($294.05) moving averages; RSI is 62, and the last 30 sessions moved at roughly 32% annualized volatility.

Revenue for the quarter ended Sep 2026 was $3.81B, up 6.9% from a year earlier, with $263.10M of net profit (a 6.9% margin).

Buyers are paying 30.1 times trailing earnings, 19% above its five-year average of 25.3. The median for its industry group is 33.9.

11 analysts follow the stock and the average call is "buy". The mean target, $391.13, sits 6.5% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$352.80 / $405.00
Average price today$367.62
Volume890.6KAvg (90d) 745.3K
Turnover$327.38M
Turnover rate1.10%of shares outstanding
Volume ratio1.40vs. recent average pace
Day amplitude1.67%
Market cap$29.81B
Float market cap$29.67B
Shares outstanding80.81M
EPS (TTM)$10.46
P/E (TTM)30.09
P/B3.37
Book value / share$108.96
Earnings yield3.32%
Dividend (TTM)$2.88 / shareYield 0.78%
Net profit (TTM)$849.35M
Net assets$8.85B
30-day volatility31.6%annualized
Avg daily range (ATR)2.20%of price, 14 days
Max drawdown (1y)-13.4%-1.4% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

C
BeStock Grade

Composite of 4 factors below, ranked against the 3734 U.S. stocks BeStock covers.

F
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

F
Income

Higher trailing yield than most of BeStock’s coverage scores higher.

A
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

11 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 32.5 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation23.5
Growth26.2
Profitability45.1
Momentum95.8
Financial health43.4
Analyst view39.3

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$391.13+6.5% vs. current price
Consensus ratingBuy11 analysts covering
Morningstar fair value$347.00Price is above fair value

Wall Street’s average 12-month target is $391.13, 6.5% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $347.00, so shares trade 5.8% above that estimate. On earnings multiple, it sits in the 75th percentile of its own five-year valuation range (pricier than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-0.5%
1 week
-0.9%
1 month
+11.3%
3 months
+8.4%
6 months
+41.9%
Year to date
+47.4%
1 year
+39.6%
Day range
$366.33$372.50
52-week range
$243.20$375.10

Technical signals

Full technicals →
Trend readStrong uptrend

6 bullish · 1 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average+1.1%Bullish
Price vs 50-day average+9.7%Bullish
Price vs 200-day average+24.9%Bullish
50-day vs 200-day50d above 200dBullish
RSI (14)62.4Bullish
MACD (12,26,9)10.59Bearish
Bollinger band position58%Bullish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How LH ranks on BeStock

Market value#663 of 3734
P/E (cheapest = 1)#2272 of 2917
Dividend yield#1954 of 2245
Closeness to 52-week high#77 of 3724
Dollar volume today#440 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

Set against the peer table: at 30.1x earnings, LH looks expensive against the market, and trades 11% below the 33.9x median among Diagnostics & Research names. The two comparisons do not always agree.

LH is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on LH.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on LH

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

LH stock: common questions

How is Labcorp Holdings stock doing today?

$367.13 is the latest print for LH, a move of -0.47% against yesterday's close of $368.88. Today's low and high so far: $366.33 and $372.50.

How big is Labcorp Holdings?

Equity value comes to $29.81B at the current price. By that measure it is number 664 of the 3753 names in our coverage.

What multiple of earnings does LH sell for?

Buyers pay 30.1 times the last twelve months of profit (EPS $10.46). Averaged over five years the multiple has been 25.3, and today's level ranks in the 75th percentile of its own history.

How far is LH from its yearly high?

The year's floor is $243.20 and the ceiling $375.10. Shares are 2.1% away from that ceiling.

Are there dividends on Labcorp Holdings shares?

It does. Payouts over the past twelve months work out to a 0.78% yield; the latest ex-dividend date was August 28, 2026.

What is the analyst view on Labcorp Holdings?

Of 11 analysts, 91% say buy, 9% hold and 0% sell. Price targets average $391.13, with the most cautious at $340.00 and the most optimistic at $420.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on LH.

Sign in to join the discussion.

Scroll to Top